Amgen is pushing deeper into cardiovascular medicine as its cholesterol drug Repatha continues to gain ground following a significant regulatory milestone. The US Food and Drug Administration granted Repatha a label expansion
The U.S. Court of Appeals for the First Circuit has refused to pause a ruling that struck down President Donald Trump’s $100,000 H-1B visa fee while an appeal proceeds. The appeals court
MoreOne of the most remarkable footnotes in Supreme Court history involves a justice whose clerks went on to claim seats on the nation’s highest bench. Only one Supreme Court justice can claim
MoreBritish equities finished the week on a subdued note, with the FTSE 100 slipping 0.27% on Friday as investors digested corporate earnings and fresh deal activity. NatWest Group (NWG.L) emerged as the
MoreJohn Healey has confirmed he will deliver his debut Budget on 28 October, pledging to “shift power and money out of Westminster” in a landmark fiscal statement. The Chancellor announced the date
MoreU.S. Citizenship and Immigration Services has made sweeping changes to nonimmigrant visa processing in 2026, creating significant new compliance challenges for employers managing international workforces. Two specific developments have sharply increased the
MoreWashington Law Deans Demand Diploma Privilege After Bar Exam Technology Collapse Leaves 600 Stranded
Three Washington law school deans are pressing the state Supreme Court to grant diploma privilege after a catastrophic bar exam failure left hundreds of graduates without a path forward. The July bar
MoreFootball’s global governing body Fifa is structurally broken and cannot be fixed from within, according to ethics professor Thomas Beschorner of the University of St Gallen. The recently concluded World Cup may
MoreThe pharmaceutical industry continues to wrestle with supply chain vulnerability, a problem that has intensified steadily since pandemic-era drug shortages first exposed critical weaknesses. Geopolitical tensions, tariff uncertainty, and ongoing national security
MoreAcas has launched a consultation on significant updates to its statutory Code of Practice on disciplinary and grievance procedures, in what is being described as an unexpected development. The Code is being
MoreMinnesota’s new law targeting so-called nudification technology is facing a serious legal challenge from Elon Musk’s artificial intelligence company xAI. The company has sued to have the law blocked, arguing it is
More
